Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product

Clinical trial NCT02840110 · TERMINATED

Trial details

NCT number: NCT02840110
Sponsor: Cogent Biosciences, Inc.
Status: TERMINATED
Study type: OBSERVATIONAL

B Cell Lymphomas Multiple Myeloma Solid Tumor HER-2 Protein Overexpression

Start date: 2016-10-01
Primary completion: 2020-10-23
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.